Sankar Srinivasan

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Yuankai Shi, Joseph S. K. Au, Sumitra Thongprasert et al. · Journal of Thoracic Oncology · 2014 · 1.6K citations · Full text

Medicine, Genetics, Oncology +14

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study

Jeffrey D. Bradley, Milada Zemanová, Virote Sriuranpong et al. · Journal of Clinical Oncology · 2025 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Molecular epidemiological prospective study of <i>EGFR</i> mutations from Asian patients (pts) with advanced lung adenocarcinoma (PIONEER).

Pan‐Chyr Yang, Yuankai Shi, Joseph S. K. Au et al. · Journal of Clinical Oncology · 2012 · 13 citations

Medicine, Oncology, Pathology +17